Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SWME January Sales Almost Beat All Of '04:
http://biz.yahoo.com/bw/050202/25065_1.html
lentinman says: http://www.investorshub.com/boards/read_msg.asp?message_id=5306874
I'm hoping this 1+ month head a shoulders fails, and becomes a "W", not overbought yet, so it could...
Good DD on IHUB Board. I really like this one, and am IN! (Bailing out at .315)
Only 4 trades=4700 shares traded in the first 20 minutes today!
This is not very encouraging...
More News for BIPH Today:
http://biz.yahoo.com/bw/050202/25771_1.html
It looks like good news to me...
GLTA,
goldrusher--Yes, the Atrium it is...
We three already have reservations there.
We wanted the Marriot's Newport Coast Villas or the Laguna Surf, but for convience, decided to stay where the SH Meeting takes place. Closer to the airport--no need for a rental car. Maybe next year we'll stay a whole week on the coast somewhere nice. This time it's mostly business.
My main concern is: We really want to see if we can arrange a tour of their HQ.
We'd love to see the pultrusion machines pumping that core out!
And everything else...
I'm just skeered all we'll get to see of CTC is:
I'm going to call IR tomorrow for the first time ever to inquire about this...
See you there gold,
Musk
OT--Kenticus Maximus:
We got the plane tickets in the mail today for the trip to Irvine SH Meeting.
Thanks!!!!!!!!!!!!
T&M
Nice Breakout to the UPside today!
Without any News...We have double the ten day average daily volume today. We have 1 million buy interest at ThomsonFN today:
http://thomson.finance.lycos.com/lycos/iwatch/cgi-bin/iw_ticker?ticker=CYTR
Things are looking pretty GOOD!!
GO CYTR!
BIPH is running...EOM
Rattman--
I agree, that was Great Free PR! from GC's CC this a.m.
GC is having a good day today, up .52--up 4.26%(Well, it was ten minutes ago-down a bit now) That's a Big move for them. The analysts liked what they heard on the CC, and called it in on their cellphones immediatly. CTC will IMO also benefit from the CC. It will probably be a delayed reaction, as a lot of the analysts that tuned in will now be discussing US, and ready to move later this week or early next. They just have to connect the dots. GC was strong on the energy distribution side, ACCC was just recently officially announced, and there is already talk this will become the industry standard. They are talking about major projects worldwide to be partnered with us. When they put it all together, we should see some institutional buying interest in the near future.
The best idea with this stock is to 1)Buy some, 2)HOLD IT! 3)Have Patience.
We should be getting a good PR from CTC this month (maybe more) IMO. Soon, we will be getting more good PR's than we can handle of new MOU's/JV's, new contracts, new test installations, news on the POLES, deals partnering CTC with GC Worldwide etc. My best guess is the pps at $15.00 12-31-05(could be more...)
GLTA,
Musk
SWME--
Swiss Medica's January Sales Orders Confirm Strong, Widespread Interest in O24 Product
Wednesday February 2, 8:00 am ET
TORONTO--(BUSINESS WIRE)--Feb. 2, 2005--Swiss Medica Inc.'s (OTCBB:SWME - News) January 2005 sales orders confirm a strong, consistent, and growing interest in the Company's flagship product, the O24 Essential Oil Pain Neutralizer. Sales orders of approximately $605,000 for the month of January 2005 nearly matched total revenues for 2004 of approximately US$628,000. Fourth quarter 2004 revenues were approximately $360,000. Full 2004 financial statements will be included in the Company's 10-K, which will be filed with the U.S. Securities and Exchange Commission by March 30th.
"This is a great way to begin the New Year," Chief Executive Officer, Raghu Kilambi said. "Our team continues to execute the proven marketing programs we began last summer, and will continue reaching consumers in this same way as we expand our marketing frequency and radius of influence. New orders from new drugstore chains in both Canada and the United States, reorders from existing customers, and a strong month of January in online and direct sales demonstrate that O24 is now becoming more widely accepted."
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24(TM) is widely available throughout Canada in leading pharmacies and natural food stores. It is currently available in Happy Harry's Discount Drugstores in the United States, or by visiting www.O24zone.com, for ordering details and store locators.
They just recently got a deal for 3,300+ Rite-Aid store in the USA to carry 024, and a nationwide multi-media ad campaing to begin soon.
This one could be a ZipCodeChanger!!!
It's worth keeping one eye on...
GLTA,
I'm new to the Board,
024 Sounds like a great product.
I could use some of that right now...
I'm going to their website and order some.
If it works good, I'll be happy, and I'll be buying this stock...
Rite Aid News is a big boost.
National Multi-media ad campaign is another.
No share dilution is a good thing.
The chart is looking healthy also.
We may have a winner here!!!
BTW, CYTR is looking tasty too!
GLTA,
Excuse me while I pat myself on the back,
I called this pullback on 1/27/05
I got some at 1.08 today.
Todays candlestick is a nice hammer, especially if we close at or above the days high.
Good Luck to All,
EP--Just read your previous FONR
message, got it...
I hope you got my warning message to you about CYTR. I'm still in with some...
Poor CPTC today...They got Good press today from GC, no buying, low volume down. It may take a few days for this news to sink in. CTC really needs a Good PR of their own soon, or I see it sub 4.00 (briefly) soon.
FONR failed to breakout today:
Could have double bottomed, turned into a double top.
Dumping now, looking for support at 1.50 or so.
CYTR is having a good day...
20+ Minutes since our last trade...
Crummy Volume Today !
General Cable Speaks of CTC in their CC:
I can't figure out how to play the whole 30 seconds at once, so I broke it down into 3 parts....
http://vhost.oddcast.com/vhost_minisite/?email=1&ss=210793&sl=461764&acc=93&e
http://vhost.oddcast.com/vhost_minisite/?email=1&ss=210816&sl=461787&acc=93&e
http://vhost.oddcast.com/vhost_minisite/?email=1&ss=210813&sl=461784&acc=93&e
I especially like the third one, where they talk about "targeting a number of major projects with CTC Worldwide!!!"
So, why are we down today ???
YES!!! CTC was mentioned in the GC CC!
I recorded it and will post it here shortly for all to listen to. We were mentioned VERY favorably!!!
We may see a boost today because of this...
Try this link for sound:
http://www.thefilebin.com/files/CTC.GC.CC.wav
GC CC is still playing,
I'm listening for mention of CTC...
General Cable Q4 Meets Expectations:
http://biz.yahoo.com/ap/050201/earns_general_cable_1.html
Their Conference Call starts at 0830 tomorrow.
If CTC is mentioned at all, it'll be good PR, and posssibly attract new investors.
General Cable Q4 2004 Earnings Are Out:
http://biz.yahoo.com/bw/050201/16091_1.html
Yep EP--You called IONA and FONR--
Before their booshes, I've been watching both all day, and kicking myself for not jumping in, both (or) either this a.m.
Shame, shame, shame,
Shame on me...
Len,
I agree with your comments. Especially the CTC advantage of: Buy the wire and our connectors, and BTW: we got poles too...You only have to deal with one supplier for all your needs...
The reason I'm compiling this list (it might take awhile, I'm only looking domestic at present) is to see "all" of our competition, and how we stack up against them. In terms of cost comparisons, ease of installation, location, and any other way we can come up with to compare.
We might as well get to know the enemy...
Composite Poles Competition:
This list is not complete yet, I just started gathering this info this a.m. I am in no way bashing CTC, but thought you all might like to know we are not alone in this field (I'm glad we have no serious competetors for ACCC) This is what I found so far:
RSI:
http://www.reinforcedplastics.com/market_focus/construction/poles.html
http://www.netcomposites.com/news.asp?2692
http://www.compositesworld.com/ct/issues/2004/February/357
http://static.highbeam.com/a/advancedmaterialsampcompositesnews/november172003/resinsystemssignsseco...
http://www.capitalideas.com/clients/rsi/profile/Fact_Sheet_2004.pdf
http://www.grouprsi.com/technology/utility_poles.aspx
Strongwell Ebert:
http://www.strongwell-ebert.com/Profile/Template.htm
http://www.strongwell.com/SpecialProducts/PowerPoles.html
http://statusreports-atp.nist.gov/reports/94-02-0025.htm
Powertrusion Int'l.
http://www.powertrusion.com/
http://www.pultruders.com/press/news-25.html
http://www.compositesworld.com/ct/issues/2003/August/164
Newmark:
http://www.newmark.com/solutions/p_delivery.asp
http://www.newmark.com/news/shownews.asp?record_no=27&database=1
http://www.newmark.com/news/shownews.asp?record_no=28&database=1
J.H. Baxter and CO:
http://www.jhbaxter.com/frc.html#frc
North Pacific Composites:
http://www.north-pacific.com/dept/polepiling/composite_pole_flyer.pdf
Composite Power Corp:
http://www.compositepower.com/contact_us.html
I found all of these in about two hours of searching the web.
Yes, this is a lot of competition, and I'm sure I'll find more.
I have no doubt that CTC Poles will find a place in this market, and will end up with a decent sized piece of this pie, as it's a huge pie, and growing...
Good Luck to All,
Musk
General Cable Earnings Announcement:
For the 4th Quarter 2004
After the close today:
http://biz.yahoo.com/research/earncal/20050201.html?t=bgc
Conference Call starts at 8:30 a.m. tomorrow:
http://biz.yahoo.com/cc/4/51764.html
Isn't it a bit strange that the Earnings Announcement and the Conference Call are not on the same day?
I wonder how this is going to effect our pps...
I hope CTC and ACCC are highlighted as a real asset to GC's future. That may attract a new Buying Frenzy!!! Tomorrow/later this week...
Link correction for last message:
This link replaces the one found at the bottom of my last message:
http://www.e-composites.com/MarketGlobal2004.htm
Free Composite Manufacturing Magazine:
I signed up, unfortunatly they mail it to you--no online access.
I did a search for CPTC--and noting came up...bummer...
Look what's in this months issue:
http://www.cmmagazine.org/cm/index.cfm
What We're About
Composites Manufacturing, (CF) is the "Official Publication of the American Composites Manufacturers Association" serving composites manufacturers in architecture, bath, cast polymer, custom molding, pultrusion, closed molding, infrastructure, marine, sports, recreation, aerospace, transportation, and automotive. As the leading source for composites education, CF is loaded with articles that teach technical competence, quality control, shop floor safety and health, regulatory standards, marketing strategies, the latest technical trends, new technologies, and the "people" side of the business. The mission of CF magazine is to support your business, and provide useful and valuable information that will give you an edge to enhance your day-to-day operations, as well as help expand your market.
Readership
CF magazine has an impressive subscriber list that reads like a who's who in the composites industry. With a 10,000 monthly readership, the publication is the "turned-to" publication by plant managers, operations managers, owners, purchasing managers, engineers, academics, and others with a vested interest in the composites industry.
P.S. I like the way SCHB keeps jumping up to be the high bidder today...This huge report is not free: http://www.cmmagazine.org/cm/index.cfm
Enjoy,
Nunley--Guest Speaker at:
(Didn't someone post that Nunley was no longer at CTC?)
APPA Engineering and Operations Technical Conference
April 17 - April 20, 2005
Peabody Hotel
Memphis, Tennessee
Contact:Kara Gouda
Email: kgouda@appanet.org
Phone:202/467-2942
http://www.appanet.org/events/index.cfm?ItemNumber=11663
Scroll down just past halfway,
1:30 – 3:00 p.m.
Concurrent Sessions II
Conductors & Poles – Equipment Selection
Which technology is your utility choosing today when it comes to building transmission and distribution lines? What type of pole? What type of conductor? This session will help you better understand the economics and applications that influence pole selection and provide an overview of new conductor technologies including composite, core, ACSS, etc.
Speakers: Bob Reisdorff, President, Laminated Wood Systems, Inc., Seward, Neb.; Greg Yakle, P.E., Superintendent of T&D Engineering, City Water Light and Power, Springfield, Ill.; John F. Nunley III, Vice President, Electrical Products, Composite Technology Corporation, Irvine, Calif.; and Sid Kamprath, Advertising and Marketing Director, Laminated Wood Systems, Inc.
JohnnyBoy000--
Posted by: PowerPole
Date:1/30/2005 4:11:20 PM
Post #23 CYTR Board on IHUB
OT--LickitySplit--Chart Reading 101:
1> First, bring up an interactive chart.
http://bigcharts.marketwatch.com/intchart/frames/frames.asp?symb=cptc&time=&freq= This one you can have any time frame.
http://stockcharts.com/def/servlet/SC.web?c=CPTC,uu[w,a]dacayyay[db][pb20!b50][vc60][iLp14,3,3!La12,.... This one is good for longer term charts.
2> Next, you need to know chart patterns.
http://www.chartpatterns.com/ Load up a chart of your choosing and find patterns in it. YHOO has a lot of chart patterns.
3> To help you understand Technical Analysis(TA) terms like Moving Averages, Stochastics, MACD, Volume, etc.
http://help.yahoo.com/help/us/fin/chart/chart-08.html Be sure to click all links in "Related Links" on the top left.
4> To understand Candlestick Charts.
http://www.candlecharts.com/about-candles-basics.html
5> There are a lot of sites that have Chart Schools.
http://stockcharts.com/education/ This is one of my favorites. Do a search, and you'll come up with many more.
6> If you don't have real-time streaming charts. Scottrade will give you Scottrader for free with registration.
http://www.scottrader.com/ This one looks really good, but has no TA options other than Volume.
7> After you get #6, download MedVed Quote Tracker, also free. It has all of the Technical Indicators.
http://www.quotetracker.com/ When logging in, use the Scottrader server, and use the same user name and password you use at Scottrader.
8> If you only have one monitor running off your computer, I recommend at least having two. I have five. If you are interested, I can help you to install multiple monitors.
This is enough for now to get you started. If you have any questions, don't hesitate to ask. I find charts to be an essential tool. I don't think I could trade effectivly without them. I can't imagine not having them in my tool box, though there are many other tools in there as well.
Best Wishes,
Good looking chart...
Not overbought, a symetrical triangle in an uptrend that broke down first (they do that a lot...). Looking tasty above 1.30=breakout on a 3 day double bottom. One year chart=inverse head and shoulders. They've had some good PR's lately. I like this one...
BTW EP--hope you saw the "buyer beware" message I left for you on Tasty Booshers Board re:CYTR
PR on BIPH and Free Report out today...
http://biz.yahoo.com/pz/050131/71728.html
Gunluvver2--Good points about CA. creosote treated wood pole replacement, and CTC's advantage by producing poles in that state. I'm sure we'll get a good piece of that pie.
imag--thanks for the links to other pole producers. I'm trying to make a list of all composite pole competitors world wide. Then, when CTC announces how much their poles will cost, we can compare... We have known for a long time we have competition for the pole business. At least ACCC is unique and has no serious competitors...
elektro, beigledog--I do recall that post of a month or so ago...and EP's posts on the towers on the coast being tested.
pick--Sorry, looks like this is all "old news"...
While it wouldn't be good if composite towers failed this early in their development, steel towers have been known to fail, and they still use them...
CTC has competition for Poles/Towers:
Thanks EP for posting this on RB.
http://www.strongwell-ebert.com/Profile/Template.htm
Click on Transmission Poles and Lattice Towers at the top.
This is the first I've ever heard of this company. Has this been discussed either here or at RB before? They look like some serious competition...Comments?
OT--LickitySplit--Chart Reading 101:
1> First, bring up an interactive chart.
http://bigcharts.marketwatch.com/intchart/frames/frames.asp?symb=cptc&time=&freq= This one you can have any time frame.
http://stockcharts.com/def/servlet/SC.web?c=CPTC,uu[w,a]dacayyay[db][pb20!b50][vc60][iLp14,3,3!La12,... This one is good for longer term charts.
2> Next, you need to know chart patterns.
http://www.chartpatterns.com/ Load up a chart of your choosing and find patterns in it. YHOO has a lot of chart patterns.
3> To help you understand Technical Analysis(TA) terms like Moving Averages, Stochastics, MACD, Volume, etc.
http://help.yahoo.com/help/us/fin/chart/chart-08.html Be sure to click all links in "Related Links" on the top left.
4> To understand Candlestick Charts.
http://www.candlecharts.com/about-candles-basics.html
5> There are a lot of sites that have Chart Schools.
http://stockcharts.com/education/ This is one of my favorites. Do a search, and you'll come up with many more.
6> If you don't have real-time streaming charts. Scottrade will give you Scottrader for free with registration.
http://www.scottrader.com/ This one looks really good, but has no TA options other than Volume.
7> After you get #6, download MedVed Quote Tracker, also free. It has all of the Technical Indicators.
http://www.quotetracker.com/ When logging in, use the Scottrader server, and use the same user name and password you use at Scottrader.
8> If you only have one monitor running off your computer, I recommend at least having two. I have five. If you are interested, I can help you to install multiple monitors.
This is enough for now to get you started. If you have any questions, don't hesitate to ask. I find charts to be an essential tool. I don't think I could trade effectivly without them. I can't imagine not having them in my tool box, though there are many other tools in there as well.
Best Wishes,
Some DD results on CYTR:
http://www.forbes.com/forbes/2004/0524/182.html
http://www.forbes.com/search/results.jhtml?MT=cytrx+corp.&sort=&aname=&author=&date=....
http://www.hoovers.com/cytrx/--ID__15904--/free-co-factsheet.xhtml?cm_ven=PAID&cm_cat=BUS&cm....
Latest News:
http://www.hoovers.com/cytrx/--ID__15904,Name__CytRx,Ticker__CYTR--/free-co-news-list.xhtml
________________________________________________________________
Comments from DewDiligence on IHUB:
Listed & Nasdaq / Biotechs / Hot Biotechs (HOTBIO)
Posted by: DewDiligence
In reply to: PowerPole who wrote msg# 2649 Date:1/29/2005 11:45:46 AM
Post #of 2651
Re: CYTR
This article from Forbes provides some background on the company and CEO:
#msg-4073074
You can call the Massachusetts Attorney General’s office for info about the state’s lawsuit against CYTR for attempting to usurp state (U Mass. Medical Center) assets.
Caveat emptor if you decide to go ahead on this one. Regards, Dew
________________________________________________________________
________________________________________________________________
PROS:
So far we have one analyst setting a 12 month price target of $7.00
They do have a number of interesting things in their pipeline. (That a number of other companies are researching also, and being first to the finish line is all important).
Any FDA fast track approval for Phase II or III will surely be a positive for pps.
The same goes for being acquired by another company.
They have had some good press about their drug Iroxanadine lately.
--------------------------------------------------------
CONS:
A CEO that's "Not in it for the money" and whose ethics are in question...(I need further research on his "ethics").
A Nobel Prize winning scientist that one journalist paints as having a wild side...IMO A lot of brilliant people have a wild side...
PR's in Barron's that are "paid for".
Good news one day, news of share dilution the next.
Lawsuits against them by the Massachusetts Attorney General’s office. (I haven't confirmed that yet).
The company has lost $81 million since it's inception (also not confirmed).
________________________________________________________________
________________________________________________________________
As DewDiligence said "Caveat emptor"--Buyer Beware!
I am not coming to any conclusions yet, my DD is not yet done.
I just thought I'd give you all something to look at until I post my conclusions. Please do your own DD and make a purchase of any stock based on your own conclusions, not by what someone posts on a message board.
Comments anyone?
Dew--Thanks for the reply...
Interesting article and comments.
I got in at the bottom after the runup two weeks ago.
Might keep a small core in case they are "the first to the finish line..."
I'm selling most of it Monday to put on something a bit more solid.
Good Luck,
Tom
EP--Buyer Beware: CYTR--Read this 1st:
I'm having second thoughts about this one after reading this...
I'll probably sell most of it Monday, and look for greener pastures...(BIPH, ISON, GEOI looks promising) Thanks...
Listed & Nasdaq / Medical - Drugs / Biotech Values – Genaera (GENR)
Posted by: DewDiligence
In reply to: None Date:9/19/2004 2:00:15 AM
Post #of 7167
How not to play RNAi:
[CytRx (CYTR) is a cheap company, but it’s cheap for a reason. The company has a checkered history, as detailed in the Forbes article below, and it is currently the target of an ethics investigation by the Commonwealth of Massachusetts. I listened to one of CYTR’s recent webcasts and it sounded like an infomercial. The company has some luminaries on its scientific advisory board, but that in itself doesn’t impress me. Caveat emptor.]
http://www.forbes.com/business/forbes/2004/0524/182.html
>>
By Seth Lubove
05.24.04
Steve Kriegsman is trying to revive a struggling biotech firm. It will take a small miracle.
For Steve Kriegsman the hardest part of his parents' deaths was watching them endure years of pain and suffering from obesity-related ailments and the onset of blindness. "Their quality of life for 15 years was horrendous," Kriegsman, 62, says quietly.
That awful experience prompted the onetime investment banker for health care companies to turn research entrepreneur. In a reverse merger with an investment fund he controlled, Kriegsman became the chief executive and largest shareholder of Cytrx Corp., a fledgling biotech outfit he's reinvented as a developer of drugs based on ribonucleic acid interference, or "gene silencing." He then persuaded such notables as 1998 Nobel Prize for Medicine winner Louis Ignarro and Craig Mello, a pioneering RNA interference researcher at the University of Massachusetts Medical School, to join the company's scientific advisory board. Says Kriegsman, "Money is not really the objective." [When you hear an executive say this, run the other way!]
So far, he's been true to his mission. Cytrx has bled $81 million in losses over its life, with no prospect of products in the near future, much less profits. Shares peaked at $47 in January 1992, when Wall Street still believed in gene silencing and related technologies; they hit bottom last year at 21 cents and recently traded at $1.60 on Nasdaq. The company's stock now faces possible delisting due to its delayed annual 10-K report filing.
If curing suffering is Kriegsman's real objective, he still has a long way to go. Gene silencing works by seizing on the RNA messengers sent out by DNA, the gene coder. RNA usually results in the creation of healthy proteins, but sometimes it goes awry and the result is diseases such as hepatitis C, AIDS, amyotrophic lateral sclerosis (Lou Gehrig's disease) and so on. The concept behind Cytrx is to shut down these messengers before they can create mischief. It's still a concept. No one has solved the challenge of delivering a strand of RNA blocker to the target cells before it breaks down or is rejected by the body.
Cytrx has disappointed before. Formed in 1985 by an Atlanta venture capitalist and an Emory University pathologist, Cytrx developed a promising treatment for heart attacks that used a combination of enzymes and synthetic chemicals to dissolve large blood clots. But after Cytrx licensed the drug in a development deal to Burroughs Wellcome (now GlaxoSmithKline), a 1995 clinical study funded by Burroughs concluded the drug was all but ineffective except at toxically high doses. Renaming it Flocor, Cytrx tried to reposition the drug as a treatment for sickle-cell anemia. That strategy flopped, too, after a 1999 Phase III clinical trial concluded it had little effect on adults afflicted with the disease, though it was more helpful on children.
Kriegsman did some bouncing around himself. After graduating from New York University with an accounting degree in 1964, he toiled in a series of financial jobs until setting up a smallish, Los Angeles-based deal shop in 1992. After drifting into health care and biotech, with occasional diversions into curiosities such as a gourmet peanut butter outfit, Kriegsman in 1999 pooled $1 million of his own and outside money to set up an investing vehicle called Global Genomics.
It didn't get far. Global Genomics eventually had to write off almost $6 million for its only investments in two small biotech companies. But by the time the investments were underwater, Kriegsman had already sold Global to Cytrx for $5.8 million in Cytrx stock. As part of the deal he became chief executive, a troubling assignment. "This company was going down the tubes," he says.
Then Kriegsman cold-called Louis Ignarro. By day a professor of pharmacology at UCLA's school of medicine, Ignarro is better known as one of the fathers of Viagra. His discoveries of the effects of nitric oxide on the body led to the development of Pfizer's blockbuster. In case anyone hasn't heard of his 1998 award, he sports a license plate on his beloved yellow Corvette that reads, "Nobel." By his own admission he is a lousy businessman. Ignarro was never entitled to any of the loot from Viagra--never mind that Pfizer sells $1.9 billion a year worth of the little blue pills. "If you want to learn how to lose money, come to me," he deadpans.
Still, it was Ignarro who steered Cytrx to the emerging field of RNA interference. "How many times have you heard of drug companies talk about a cure?" he asks. This approach may someday cure "by turning off and eliminating defective genes that cause disease," he says.
There was a time when RNA blocking had considerable appeal. Not long ago the visionaries were preaching something called "antisense," notably at the Foster City, Calif. biotech company Gilead Sciences. Named after one of DNA's two strands in its double-helix structure, the antisense drugs were supposed to latch onto the sense strand of RNA, thereby blocking it from producing diseased proteins. RNA interference is more or less the same idea, except (for what it's worth) that antisense is a much longer RNA strand that is more likely to be rejected by the body. Gilead sold its antisense patents to Isis Pharmaceuticals in Carlsbad, Calif.
Gene silencing has its boosters, many of them clustered around the UMass medical school, where Kriegsman has arranged licensing deals in exchange for 1.8 million shares, or 6.4% of Cytrx, and milestone payments that could amount to $12 million, depending on what products are developed, if any. Other firms have also licensed UMass' gene silencing science. So, even if the concept amounts to something, there's no assurance that Cytrx will be first to the finish line.
C'ya
DD--Can you be more specific please?
"CYTR has questionable management ethics. I wouldn’t go near them."
I and a few others would be very interested in your reply.
I just noticed them for the first time two weeks ago on the CNBC ticker up 50% on super high volume, so have no idea of their history, or ethics. Their last PR was a "paid for" piece in Barron's...
TIA
Good Long Entry--CYTR:
(Nasdaq Small Cap)$1.50 at the close today.
Nice looking 3 year chart. At it's second low, ready to breakout on a nice double bottom. It had the largest volume week in 3 years last week after good news. They are working on a HIV Vaccine, ALS--Lou Gehrig's Disease, and diabetes.
Check it out, I just made a IHUB Board for the Cytrx Corp. Plenty of links there to do some quick DD.
Anyone know anything about this company (good or bad) that needs to be brought to the attention of potential investors? TIA
EP--What with the CTC board?
I can totally understand no sounds in posts.
I can see how animations may irritate some.
Now charts are getting a lot of flack too...
These folks need to lighten up a little and learn how to have some FUN!
I'm glad folks over here don't feel like pedalmasher...
Posted by: pedalmasher
Date:1/28/2005 4:08:58 PM
Post 1122
"I'll speak when I have something useful to say. I don't know (and won't pretend to know) much about market technicals or charts or any of that black box magic voodoo stuff, but I do know about the electric transmission industry and will help out with questions in that regard. Whever I can."
Oh, and on that chart that sparked this reply, I was talking very long term, like it would reach my target in 6 months or so, not a quick boosh there right away. Doesn't matter, we'll be up at 9.00 in six months regardless...
BEER !!!.......scroll down...
Guinness is Good for you, St. Pauli Girl is GREAT for me!
Cheers!!!
BEER !!!.......scroll down...
Guinness is Good for you, St. Pauli Girl is GREAT for me!
Cheers!!!